{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:20:11Z","timestamp":1771550411961,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2017.00032","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T08:34:59Z","timestamp":1487838899000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["The Efficacy and Tolerability of the Clonidine Transdermal Patch in the Treatment for Children with Tic Disorders: A Prospective, Open, Single-Group, Self-Controlled Study"],"prefix":"10.3389","volume":"8","author":[{"given":"Pan-Pan","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Qi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang-Zi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2012.05.043","article-title":"Pharmacological treatment of tic disorders and Tourette syndrome","volume":"68","author":"Roessner","year":"2013","journal-title":"Neuropharmacology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.lpm.2007.11.007","article-title":"Tics and Tourette syndrome: diagnosis, course and treatment principles","volume":"37","author":"Houeto","year":"2008","journal-title":"Presse Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/08830738060210080601","article-title":"Tourette syndrome: diagnosis, strategies, therapies, pathogenesis, and future research directions","volume":"21","author":"Olson","year":"2006","journal-title":"J Child Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.paed.2010.03.013","article-title":"Update on tic disorders and Tourette syndrome","volume":"20","author":"Stern","year":"2010","journal-title":"Paediatr Child Health"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.neubiorev.2012.09.008","article-title":"Systematic review: pharmacological treatment of tic disorders \u2013 efficacy of antipsychotic and alpha-2 adrenergic agonist agents","volume":"37","author":"Weisman","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.spen.2006.09.004","article-title":"Tic disorders in childhood","volume":"13","author":"Dooley","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/cbl.20223","article-title":"Tackling tics: advances in the clinical management of tic disorders","volume":"30","author":"Conelea","year":"2014","journal-title":"Brown Univ Child Adolesc Behav Lett"},{"key":"B8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/1756285610390261","article-title":"Treatment strategies for tics in Tourette syndrome","volume":"4","author":"Eddy","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jocrd.2014.04.006","article-title":"Pharmacological treatment of Tourette syndrome","volume":"3","author":"Gilbert","year":"2014","journal-title":"J Obses Compul Rel Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.pcl.2015.03.007","article-title":"Advances in Tourette syndrome: diagnoses and treatment","volume":"62","author":"Serajee","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"B11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/nyas.12296","article-title":"The future of tic disorder treatment","volume":"13","author":"Bennett","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.psychres.2013.10.009","article-title":"Clonidine in Tourette syndrome and sensorimotor gating","volume":"215","author":"Eapen","year":"2014","journal-title":"Psychiatry Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ana.410210313","article-title":"Clonidine and Gilles dela Tourette\u2019s syndrome: double-blind study using objectiverating methods","volume":"21","author":"Goetz","year":"1987","journal-title":"Ann Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF00314429","article-title":"Tourette syndrome: successful treatment with clonidine and oxycodone","volume":"233","author":"Sandyk","year":"1986","journal-title":"J Neurol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/00007611-198809000-00009","article-title":"Clonazepam, haloperidol, and clonidine in tic disorders","volume":"81","author":"Troung","year":"1988","journal-title":"South Med J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ejpn.2013.01.005","article-title":"Tourette syndrome and comorbid ADHD: current pharmacological treatment options","volume":"17","author":"Rizzo","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/01.chi.0000199022.38334.a7","article-title":"Review of Handbook of Tourette\u2019s syndrome and related tic and behavioral disorders: second edition","volume":"45","author":"Bloch","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cct.2013.08.012","article-title":"Detecting a clinically meaningful change in tic severity in Tourette syndrome: a comparison of three methods","volume":"36","author":"Jeon","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"B19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1089\/cap.2010.0149","article-title":"Defining treatment response in pediatric tic disorders: a signal detection analysis of the Yale global tic severity scale","volume":"21","author":"Storch","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"B20","first-page":"491","article-title":"Pharmacological treatment of tic disorders in children","volume":"27","author":"Zheng","year":"2012","journal-title":"Chin J Pract Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pediatrneurol.2008.12.014","article-title":"Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome","volume":"40","author":"Hedderick","year":"2009","journal-title":"Pediatr Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s13311-013-0215-4","article-title":"Treatment of Tourette syndrome","volume":"11","author":"Kurlan","year":"2014","journal-title":"Neurotherapeutics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/00048670802277222","article-title":"Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine transdermal patch for the treatment of tic disorders","volume":"42","author":"Du","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3760\/j:issn:1006-7884.2000.02.019","article-title":"Short-term effects of treatment with clonidine transdermal patch in children","volume":"33","author":"Zhong","year":"2000","journal-title":"Chin J Psychiatry"},{"key":"B26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/00004583-200203000-00013","article-title":"Risperidone versus clonidine in the treatment of children and adolescents with Tourette\u2019s syndrome","volume":"41","author":"Gaffney","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3969\/j.issn.1672-108X.2006.06.004","article-title":"Clinical trial of the clonidine transdermal patch for the treatment of tic disorders in children","volume":"12","author":"Zhang","year":"2006","journal-title":"J Pediatr Pharm"},{"key":"B28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12888-015-0430-0","article-title":"Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study","volume":"15","author":"Cuenca","year":"2015","journal-title":"BMC Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1212\/WNL.35.3.343","article-title":"Short- and long-term treatment of Tourette\u2019s syndrome with clonidine: a clinical perspective","volume":"35","author":"Leckman","year":"1985","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","article-title":"Clonidine treatment of Gilles de la Tourette\u2019s syndrome","volume":"48","author":"Leckman","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"B31","first-page":"2325","article-title":"Tic disorders","volume-title":"Kaplan Hi: Comprehensive Textbook of Psychiatry","author":"Hanna","year":"1995"},{"key":"B32","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.1176\/appi.neuropsych.11010032","article-title":"Good response to clonidine in Tourette syndrome associated with chromosomal translocation involving the IMMP2 L gene","volume":"24","author":"Katuwawela","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3233\/BEN-120276","article-title":"Treatment of Tourette syndrome with cannabinoids","volume":"27","author":"M\u00fcller-Vahl","year":"2013","journal-title":"Behav Neurol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3969\/j.issn.1008-6579.2006.02.002","article-title":"New concepts of tic disorders and progress in diagnosis and treatment","volume":"14","author":"Zheng","year":"2006","journal-title":"Chinese J Child Health Care"},{"key":"B35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1056-4993(18)30457-7","article-title":"The pharmacological treatment of tic disorders","volume":"4","author":"Chappell","year":"1995","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"B36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics: a randomized controlled trial","volume":"58","author":"Tourette\u2019s Syndrome Study Group","year":"2002","journal-title":"Neurology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S1474-4422(02)00038-8","article-title":"The placebo effect in neurological disorders","volume":"1","author":"De la Fuente-Fern\u00e1ndez","year":"2002","journal-title":"Lancet Neurol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1176\/appi.ajp.161.8.1485","article-title":"Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder","volume":"161","author":"Huppert","year":"2004","journal-title":"Am J Psychiatry"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00032\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:37:11Z","timestamp":1568853431000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00032\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3389\/fneur.2017.00032","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}